Episode 251: PREMIUM – a new heart failure study and much, much more

In episode 251, PREMIUM Mike and James look at the most recent update of the ACCORD trial and find not a lot. We then look at a relatively new class of medication (neprilysin inhibitor) and actually find something but realise it all needs to be put into context.

 

The full content of this Podcast, including the audio file, is available to Premium Members only. Click to find out the benefits of having a Premium Membership.

Why Get A Premium Membership ?